PineBridge Investments’s Ionis Pharmaceuticals IONS Stock Holding History

PineBridge Investments’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,959	Closed	-$1.02M	–	758
2022 Q4	$1.02M	Buy	+26,959	New	+$1.13M	0.01%	400
2019 Q3	–	Sell	-200	Closed	-$13K	–	1177
2019 Q2	$13K	Hold	200	–	–	﹤0.01%	1057
2019 Q1	$16K	Hold	200	–	–	﹤0.01%	1008
2018 Q4	$11K	Sell	200 -100	-33%	-$5.1K	﹤0.01%	1050
2018 Q3	$15K	Buy	+300	New	+$14.1K	﹤0.01%	1068

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PineBridge Investments's IONS Position: Q1 2023 in Review

PineBridge Investments sold out of Ionis Pharmaceuticals (IONS) in Q1 2023, closing a stake of 26,959 shares — an estimated $1.02M sold.

PineBridge Investments first reported a position in IONS in Q3 2018 and held it in 5 quarters. The position peaked at $1.02M in Q4 2022. 313 funds tracked by Wall St. Rank hold IONS as of Q1 2023.

PineBridge Investments reported no remaining Ionis Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
PineBridge Investments sold 26,959 Ionis Pharmaceuticals shares in Q1 2023, an estimated $1.02M.
PineBridge Investments first reported a position in Ionis Pharmaceuticals in Q3 2018 and held it in 5 quarters.
PineBridge Investments's Ionis Pharmaceuticals position peaked at $1.02M in Q4 2022.
313 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2023.

Based on PineBridge Investments's 13F filing for Q1 2023, filed 12 May 2023.